Daihan Scientific, a South Korean laboratory equipment manufacturer, has localized production of lab instruments that the domestic market previously imported and now sells them in more than 70 countries, Chosun Ilbo reports.

For R&D managers at Korean universities and institutes, the shift matters for procurement. Instruments that once carried import lead times, foreign-currency pricing and overseas service contracts can now be sourced domestically, with local technical support and spare parts.

The company's export footprint — spanning more than 70 nations — signals that its localized product lines meet performance expectations in competitive Western and Asian markets, not just protected domestic demand.

What the report does not specify is which instrument categories Daihan has localized, the R&D spending behind the effort, or the revenue split between domestic and export sales. Buyers evaluating a switch from established Western vendors will need to benchmark measured specifications — temperature stability, calibration drift, throughput — against incumbent equipment on a model-by-model basis rather than relying on the localization claim itself.

The announcement arrives as Korean policymakers push to reduce dependence on imported research equipment in public-sector labs, a procurement priority that tends to favor domestic suppliers in institutional tenders.

Chosun Ilbo's report is a milestone account rather than a technical one: it documents the export achievement but provides no sample performance data, certification details or customer names. Procurement teams should treat it as a signal to run head-to-head evaluations, not as sufficient evidence on its own.

Daihan Scientific's next test will be whether its localized instruments can win reference customers at major research universities outside Korea, where the brand competes without home-market advantages.